- Report
- November 2023
- 197 Pages
Global
From €4656EUR$4,950USD£4,030GBP
- Report
- June 2023
- 141 Pages
Global
From €2116EUR$2,249USD£1,831GBP
€2351EUR$2,499USD£2,034GBP
- Report
- January 2023
- 180 Pages
Global
From €2980EUR$3,168USD£2,579GBP
€3387EUR$3,600USD£2,931GBP
- Report
- December 2022
- 139 Pages
Global
From €3763EUR$4,000USD£3,256GBP
- Report
- July 2023
- 114 Pages
Global
From €5174EUR$5,500USD£4,477GBP
- Report
- September 2023
- 110 Pages
Global
From €5597EUR$5,950USD£4,844GBP
- Report
- November 2023
- 288 Pages
Global
From €5268EUR$5,600USD£4,559GBP
- Report
- May 2023
- 250 Pages
Global
From €3763EUR$4,000USD£3,256GBP
€4703EUR$5,000USD£4,070GBP
- Report
- October 2023
- 142 Pages
Global
From €2351EUR$2,499USD£2,034GBP
- Report
- January 2023
- 112 Pages
Global
From €2351EUR$2,499USD£2,034GBP
- Report
- January 2023
- 170 Pages
Global
From €2352EUR$2,500USD£2,035GBP
- Report
- June 2023
- 277 Pages
Global
From €5475EUR$5,820USD£4,738GBP
- Report
- March 2019
- 501 Pages
Global
From €4232EUR$4,499USD£3,663GBP
- Report
- April 2022
- 110 Pages
Global
From €5597EUR$5,950USD£4,844GBP
- Report
- July 2023
- 73 Pages
China
From €3292EUR$3,500USD£2,849GBP
- Report
- October 2021
- 118 Pages
Global
From €4609EUR$4,900USD£3,989GBP
- Report
- January 2022
- 120 Pages
Global
From €2352EUR$2,500USD£2,035GBP
- Report
- July 2022
- 100 Pages
Global
From €2070EUR$2,200USD£1,791GBP
€2587EUR$2,750USD£2,239GBP
- Report
- July 2022
- 119 Pages
Global
From €3798EUR$4,038USD£3,287GBP
€4468EUR$4,750USD£3,867GBP
- Report
- January 2022
- 115 Pages
Global
From €3798EUR$4,038USD£3,287GBP
€4468EUR$4,750USD£3,867GBP

The Artificial Pancreas is a medical device that uses biomaterials to regulate blood glucose levels in people with diabetes. It is composed of a continuous glucose monitor (CGM) and an insulin pump, which are connected to a computer algorithm that automatically adjusts insulin delivery. The Artificial Pancreas is designed to mimic the natural pancreas, which produces insulin in response to changes in blood glucose levels. The device is intended to reduce the burden of diabetes management and improve glycemic control.
The Artificial Pancreas market is growing rapidly, driven by increasing prevalence of diabetes, technological advancements, and increasing awareness of the benefits of the device. The market is expected to be further driven by increasing investments in research and development, and the introduction of new products.
Some of the key players in the Artificial Pancreas market include Medtronic, Johnson & Johnson, Insulet Corporation, Dexcom, Tandem Diabetes Care, and Bigfoot Biomedical. Show Less Read more